Animal experiments in decorin-null mice with myocardial infarction (70) or in hamster and mice models of lung fibrosis (73–75) showed both decorin requirement for proper fibrotic evolution of tissue injury and the potential therapeutic anti-fibrotic effect of decorin administration. The gene discussed is DCN; the disease is myocardial infarction.